Search research articles
Contact Us
Filters
Showing results (171-180 of 233) with videos related to
Page
of 24
Sort By:
American Journal of Cancer Research
|
April 9, 2024
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor
Po-Ting Lin, Yu-Chun Hsu, Yu-Ting Kao, et al.
Plos One
|
April 15, 2020
Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment
Shao-Ming Chiu, Ming-Chao Tsai, Chun-Yen Lin, et al.
American Journal of Cancer Research
|
May 9, 2022
Combination of CRAFITY score with Alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
Wei Teng, Chen-Chun Lin, Chung-Wei Su, et al.
Journal of Viral Hepatitis
|
August 22, 2019
Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience
Ming-Chao Tsai, Chun-Yen Lin, Chao-Hung Hung, et al.
Viruses
|
February 26, 2022
The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir
Cheng-Kun Wu, Li-Wei Chen, Te-Sheng Chang, et al.
Forensic Science International
|
September 19, 2014
Diatomological investigation in sphenoid sinus fluid and lung tissue from cases of suspected drowning
Chun-Yen Lin, Wen-Chien Yen, Hsing-Mei Hsieh, et al.
Cancers
|
August 7, 2021
A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Mai-Huong T Ngo, Sue-Wei Peng, Yung-Che Kuo, et al.
Hepatology (Baltimore, Md.)
|
January 21, 2022
Innate-like bystander-activated CD38<sup>+</sup> HLA-DR<sup>+</sup> CD8<sup>+</sup> T cells play a pathogenic role in patients with chronic hepatitis C
Chien-Hao Huang, Jian-He Fan, Wen-Juei Jeng, et al.
Oncoimmunology
|
October 10, 2015
Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion
Li-Yuan Chang, Yung-Chang Lin, Jy-Ming Chiang, et al.
Journal of Clinical and Translational Hepatology
|
March 11, 2026
Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis
Yuan-Hung Kuo, Wei Teng, Yen-Hao Chen, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 233) with videos related to
Sort By:
Page
of 24
American Journal of Cancer Research
|
April 9, 2024
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor
Po-Ting Lin, Yu-Chun Hsu, Yu-Ting Kao, et al.
Plos One
|
April 15, 2020
Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment
Shao-Ming Chiu, Ming-Chao Tsai, Chun-Yen Lin, et al.
American Journal of Cancer Research
|
May 9, 2022
Combination of CRAFITY score with Alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma
Wei Teng, Chen-Chun Lin, Chung-Wei Su, et al.
Journal of Viral Hepatitis
|
August 22, 2019
Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience
Ming-Chao Tsai, Chun-Yen Lin, Chao-Hung Hung, et al.
Viruses
|
February 26, 2022
The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir
Cheng-Kun Wu, Li-Wei Chen, Te-Sheng Chang, et al.
Forensic Science International
|
September 19, 2014
Diatomological investigation in sphenoid sinus fluid and lung tissue from cases of suspected drowning
Chun-Yen Lin, Wen-Chien Yen, Hsing-Mei Hsieh, et al.
Cancers
|
August 7, 2021
A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Mai-Huong T Ngo, Sue-Wei Peng, Yung-Che Kuo, et al.
Hepatology (Baltimore, Md.)
|
January 21, 2022
Innate-like bystander-activated CD38<sup>+</sup> HLA-DR<sup>+</sup> CD8<sup>+</sup> T cells play a pathogenic role in patients with chronic hepatitis C
Chien-Hao Huang, Jian-He Fan, Wen-Juei Jeng, et al.
Oncoimmunology
|
October 10, 2015
Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion
Li-Yuan Chang, Yung-Chang Lin, Jy-Ming Chiang, et al.
Journal of Clinical and Translational Hepatology
|
March 11, 2026
Prognostic Nutritional Index Predicts Outcomes in Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab: A Propensity Score-matched Analysis
Yuan-Hung Kuo, Wei Teng, Yen-Hao Chen, et al.
Page
of 24